← Back to search

Krystal Biotech Inc

KRYS · NASDAQ

Biological Product (except Diagnostic) Manufacturing

Krystal Biotech, Inc. is a pivotal-stage gene therapy company leveraging its novel, redosable gene therapy platform and in-house manufacturing capabilities to develop therapies to treat serious rare diseases.

ESG Scores

Overall ESG
5.0
Environmental
6.4
Social
4.0
Governance
5.0

Gender Diversity

Female Directors0.22219999999999998%
Female Executives0.28378378378378377%
CEO GenderMale